Kodiak Sciences Management
Management criteria checks 2/4
Kodiak Sciences' CEO is Victor Perlroth, appointed in Jun 2009, has a tenure of 13.83 years. total yearly compensation is $113.37M, comprised of 0.6% salary and 99.4% bonuses, including company stock and options. directly owns 5.06% of the company’s shares, worth MX$218.52M. The average tenure of the management team and the board of directors is 3.9 years and 4.8 years respectively.
Key information
Victor Perlroth
Chief executive officer
US$113.4m
Total compensation
| CEO salary percentage | 0.6% |
| CEO tenure | 13.8yrs |
| CEO ownership | 5.1% |
| Management average tenure | 3.9yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2022 | n/a | n/a | -US$334m |
| Sep 30 2022 | n/a | n/a | -US$357m |
| Jun 30 2022 | n/a | n/a | -US$347m |
| Mar 31 2022 | n/a | n/a | -US$312m |
| Dec 31 2021 | US$113m | US$655k | -US$267m |
| Sep 30 2021 | n/a | n/a | -US$220m |
| Jun 30 2021 | n/a | n/a | -US$189m |
| Mar 31 2021 | n/a | n/a | -US$159m |
| Dec 31 2020 | US$9m | US$591k | -US$133m |
| Sep 30 2020 | n/a | n/a | -US$102m |
| Jun 30 2020 | n/a | n/a | -US$78m |
| Mar 31 2020 | n/a | n/a | -US$64m |
| Dec 31 2019 | US$18m | US$526k | -US$47m |
| Sep 30 2019 | n/a | n/a | -US$46m |
| Jun 30 2019 | n/a | n/a | -US$44m |
| Mar 31 2019 | n/a | n/a | -US$41m |
| Dec 31 2018 | US$6m | US$428k | -US$41m |
| Sep 30 2018 | n/a | n/a | -US$38m |
| Jun 30 2018 | n/a | n/a | -US$32m |
| Mar 31 2018 | n/a | n/a | -US$31m |
| Dec 31 2017 | US$824k | US$388k | -US$28m |
Compensation vs Market: Victor's total compensation ($USD113.37M) is above average for companies of similar size in the MX market ($USD532.66K).
Compensation vs Earnings: Victor's compensation has increased whilst the company is unprofitable.
CEO
Victor Perlroth (49 yo)
13.8yrs
Tenure
US$113,371,207
Compensation
Dr. Victor Perlroth, M.D co-founded Kodiak Sciences Inc. in 2009 and serves as its co-founder, Chairman, President and Chief Executive Officer. Dr. Perlroth serves as Chief Executive officer since June 200...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.8yrs | US$113.37m | 5.06% $ 218.5m | |
| Senior VP | 8.8yrs | US$27.87m | 0.33% $ 14.4m | |
| Chief Medical Officer & Chief Development Officer | 4.6yrs | US$27.95m | 0.11% $ 4.7m | |
| Senior VP of Digital Transformation & Chief Information Officer | 1.2yrs | no data | no data | |
| Senior Vice President of Discovery Medicine | 5.5yrs | US$321.91k | no data | |
| Senior Vice President of Chemical Development & Manufacturing | less than a year | no data | no data | |
| Senior Vice President of Quality Operations | 3.3yrs | no data | no data | |
| Senior Vice President of Clinical Research & Translational Medicine | less than a year | no data | no data |
3.9yrs
Average Tenure
49.5yo
Average Age
Experienced Management: KOD *'s management team is considered experienced (3.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.8yrs | US$113.37m | 5.06% $ 218.5m | |
| Lead Independent Director | 4.8yrs | US$471.07k | 0.019% $ 829.4k | |
| Independent Director | 7.6yrs | US$389.82k | 0% $ 0 | |
| Independent Director | 4.8yrs | US$436.07k | 0.0019% $ 82.9k | |
| Independent Director | 4.8yrs | US$442.18k | 0% $ 0 | |
| Independent Director | 3yrs | US$460.97k | 0.050% $ 2.2m | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data |
4.8yrs
Average Tenure
57.5yo
Average Age
Experienced Board: KOD *'s board of directors are considered experienced (4.8 years average tenure).